Happy 28th birthday, Herceptin! The FDA approved it on this day in 1998, & HER2+ breast cancer hasn't been the same since. So many people are alive today thanks to the patients in those first trials & the researchers who dedicated their careers to it. accessdata.fda.gov/drugsatfd…

RT @JaniceTNBCmets: So proud to have been part of IV: Our Lives, from live readings to filming. 🩷💙💚 Built from hundreds of interviews, prim…

Now out in @JCO_ASCO 👉Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive #BreastCancer: Secondary Analyses of EA1181/CompassHER2 pCR pubmed.ncbi.nlm.nih.gov/4262… @DrEricWiner @DrAnnaWeiss @MridulaGeorgeMD @melindatelli @AnnPartridgeMD @DrLisaCarey @awolff

📣We are seeking participants with #BreastCancer for a study exploring their experiences with #ctDNA blood tests. If you choose to take part, you will complete an online survey that takes about 15 to 20 minutes. The goal of this survey is to understand what you know about circulating tumor DNA (ctDNA) blood tests. By participating you will help us understand what patients and providers need to know about using these tests in clinical care. 👉Survey Link: redcap.link/ctdna_patient For more information email: DFCIBreastTrials@dfci.Harvard.edu #BreastCancerResearch #CancerResearch #PatientExperience #MRD #LiquidBiopsy

Etcamah Approved for iESR1/i-Mutated HR /HER2- Advanced Breast Cancer oncologynurseadvisor.com/new…

This call to action was led by Hans Wildiers and @ChristineDesme2, with @Seamusoreilly18, @christeeny513 & many others. Read the accompanying GRASP blog post here: graspcancer.org/when-patient…

Check out this recent review on antibody-drug conjugates in #BreastCancer: the first-line and curative setting. pubmed.ncbi.nlm.nih.gov/4259… @PTarantinoMD #NicoleOdzer #ADCs #TNBC #HER2

FDA has approved imlunestrant in combo w/ abemaciclib for adults w/ ER+/HER2-/ESR1 mutated #metastaticbreastcancer after disease progression on at least 1 line of endocrine therapy. Based on EMBER-3 PFS results. ⚠️ OS results not yet mature #bcsm #OncTwitter #regulatory #MBC

Etcamah Approved for iESR1/i-Mutated HR /HER2- Advanced Breast Cancer empr.com/news/fda-approves-e…

Evidence-Based Framework Supports CDT for Breast Cancer-Related Lymphedema oncologynurseadvisor.com/new…

I used to believe vaccines were safe and effective, saved millions of lives. Then I actually stopped, did my own research and read the literature and the science And now? I believe it even more

Recent FDA Drug Approvals Rely on Fewer Studies, More Industry Funding cancertherapyadvisor.com/new…

Happy #CNSWeek2026! @NACNS @oncologynursing

Unfortunately, many doctors know about the existence of "inflammatory breast cancer (IBC)," but few know how to make the proper diagnosis in a timely manner. jamanetwork.com/journals/jam…

Chemo-Free Combo of 4 Targeted Therapies Shows Promise in Metastatic Breast Cancer cancertherapyadvisor.com/new…

Join us Sept. 22 in Boston for the @OncLive State of the Science Summit on #BreastCancer. This free, in-person meeting is designed for academic & community-based physicians and health care professionals and will cover: • CDK4/6-based therapies in HR+ breast cancer • Treatment sequencing in advanced/metastatic HR+/HER2- breast cancer • Advancements for HER2+ breast cancer • Updates in triple negative breast cancer • Plus Live Q&A Sessions Register today: onclive.com/events

In this episode of #BreastCancerBreakthroughs, Dr. Harold Burstein (@DrHBurstein) and Dr. Erica Mayer (@elmayermd) discuss key updates from #ASCO2026 on the #persevERA trial and oral #SERDs for metastatic breast cancer. piped.video/QKS1MZoQSEw?si=c-mh…

13 New Breast Cancer Studies Your Patients Want to Know About This Summer oncologynurseadvisor.com/fea…

#NationalDogDay.....honor that special companion with a donation: ibcresearch.org/get-involved…

Revtorpyk Approved for iPIK3CA/i Wild-Type Advanced Breast Cancer cancertherapyadvisor.com/new…